HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
The HDL hypothesis stating that simply raising HDL cholesterol (HDL-C) may produce cardiovascular benefits has been questioned recently based on several randomized clinical trials using CETP inhibitors or niacin to raise HDL-C levels. However extensive pre-clinical data support the vascular protect...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2015-09-01
|
| Серии: | Frontiers in Pharmacology |
| Предметы: | |
| Online-ссылка: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00187/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|